Contact details

Tom Page

T: +44 20 7809 2021 M: +44 7813 600 516 Email Tom | Vcard Office: London

Awards

Equity capital markets

Equity capital markets

Tom Page Partner

Contact details

Tom Page

Tom Page
Partner

T: +44 20 7809 2021 M: +44 7813 600 516 Email Tom | Vcard Office: London

Tom has extensive experience advising on all aspects of corporate finance including capital markets, takeovers and M&A. Clients value Tom's pragmatic and commercial approach and his ability to guide clients smoothly through transactions.
  • Profile
  • Services
  • Sectors

Tom's practice includes advising clients on IPOs, Code takeovers, private company M&A including mid and large cap and cross border transactions, restructuring and joint ventures.

He has particular experience advising mid-cap investment banks and working on transactions in the life sciences sector.

  • Public and private M&A
  • Restructuring and insolvency
  • Joint ventures
  • Equity capital markets
  • Corporate

easyHotel

Advised easyHotel on its £139 million takeover.

BTG plc

Advised on the £177 million takeover of Biocompatibles plc.

Kalibrate

Advised Kalibrate Technologies on its £29 million takeover by Hanover Active Equity Fund.

Whitewash and advisory

Advised on various Code whitewashes and advisory work.

De Vere

Advised on the sale of the Grand Hotel, Brighton.

Feedback plc

Advised Feedback plc on acquisitions of Cambridge Computed Images Ltd and TexRAD Ltd.

AIM Group Ltd

Sale of US operations and UK holding company of aviation manufacturing company to buyer backed by Liberty Hall Capital for US$220 million.

AIM Group Plc

Advised on the sale of this specialist manufacturer of aircraft interiors to management, backed by Lloyds Development Capital

Gentoo Group

Advised on its acquisition of the assets of AIM listed Romag Holdings plc by way of a pre-pack administration.

The Pension Protection Fund

Advised on various matters including the restructuring of Monarch Airlines.

BTG plc

Advised in relation to the pre-pack acquisition of certain assets of SCM Pharma.

JP Morgan

Advised JP Morgan on its container ship joint venture with global shipping company Bernhard Schulte.

Maas Capital

Advised in relation to a joint venture in the offshore sub sector.

International shipowner

Advised on its entry into and exit from a VLGC owning joint venture.

Manolete Partners

Advised Manolete Partners on its £76m AIM IPO and placing.

BTG

Advised BTG plc on its £160m joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Numis and Hornby

Advised Numis in relation to Hornby’s placing and move from the main market to AIM.

Novacyt

Advised Paris-listed medical diagnostics company Novacyt on its dual listing on AIM.

Hotel Chocolat

Advised Hotel Chocolat on its AIM IPO and secondary fundraising.

Northland

Advised Northland on its role as Nomad to Evgen Pharmaceuticals on its AIM IPO.

Numis and Argentex Group

Advised Numis in its role as nominated adviser and broker on the AIM IPO of Argentex Group plc and related £46 million placing of new and existing shares.

easyHotel plc

Advised easyHotel on its AIM IPO, subsequent secondary fundraisings, takeover and de-listing.

finnCap

Advised finnCap on its role as Nomad and broker to KRM22 on its AIM IPO.

NetScientific

Advised NetScientific plc on its acquisition of EMV Capital Limited and placing, including a Rule 9 waiver.

Oriel

Advised Oriel in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and its re-admission to AIM.

BTG plc

Advised BTG plc on the joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Advised BTG plc on the £177 million takeover of Biocompatibles plc.

De Vere

Advised De Vere on the sale of the Grand Hotel, Brighton.

Numis Securities

Advised Numis Securities in relation to Hornby plc's placing and move from the main market to AIM.

Kalibrate Technologies plc

Advised Kalibrate Technologies plc on its admission to trading on AIM.

More: Corporate
  • Life sciences
  • Technology
  • Shipping

Tom is a corporate lawyer with particular experience in the life sciences sector. He advises on equity capital markets transactions, including IPOs and secondary fundraisings, private M&A and public takeovers. Tom acts for private and listed companies and for life sciences teams at brokers and investment banks. Clients value Tom’s pragmatic and commercial approach and his ability to guide them smoothly through transactions.

Tom’s life sciences experience includes advising:

BTG

Advised in relation to its joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc

Novacyt SA

Advised Novacyt SA, a French incorporated diagnostics company with HQ in the UK, on its AIM IPO which constituted a dual listing with the existing listing on Euronext Growth Paris

Northland Capital Partners

Advised in its role as Nomad and broker to Evegen Pharma on its AIM IPO

A FTSE 250 healthcare company

Advised in relation to a private acquisition of a university spin out.

Multi-jurisdictional joint venture

Advised in relation to a multi-jurisdictional joint venture over Finnish pharmaceuticals company

Oriel

Advised in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and re-admission to AIM

BTG

Advised on the pre-pack acquisition of assets of SCM Pharma

BTG

Advised on its £177 million takeover of Biocompatibles plc by way of scheme of arrangement

NetScientific

Advised on its acquisition, placing and Rule 9 waiver

More: Life sciences

Kalibrate Technologies Plc

Advised in connection with AIM IPO of Kalibrate Technologies Plc, a provider of proprietary software-based products and services to the global petroleum retail industry, and in connection with its subsequent recommended takeover.

Nomad

Advised Nomad in connection with acquisition and readmission to AIM of Rex Bionics, pioneer of the REX Robot technology that enhances the mobility of wheel-chair users and on its subsequent secondary placing.

Nomad

Advised Nomad and joint brokers in connection with AIM IPO of BPO company, Ibex Global Solutions.

More: Technology

Hadley Shipping

Advised Hadley Shipping, a 25% shareholder in Foreland Shipping, the MoD's strategic sealift provider, on its acquisition of the 25% stakes of John Fisher & Sons plc and Bibby Line.

JP Morgan

Advised JP Morgan on its container ship joint venture with global shipping company Bernhard Schulte.

Goldenport Holdings

Advised Goldenport on its placing and open offer to finance acquisitions of newbuild vessels through class one and related party transactions.

Maas Capital

Advised in relation to a joint venture in the offshore sub sector.

More: Shipping

Awards

Equity capital markets

Equity capital markets

Latest news & insights

13 Jul 2020

From Insights

COVID-19 considerations for life sciences M&A

This note sets out some COVID-19 considerations for M&A which are specific to the life sciences sector.

More

29 Apr 2020

From Insights

Equity fundraising considerations for AIM companies during COVID-19

COVID-19 and related business challenges have forced many companies to review their balance sheets and particularly their cash positions. Many AIM listed companies hav..

More

23 Mar 2020

From News

Stephenson Harwood advises Hotel Chocolat on £22 million fundraising

Law firm Stephenson Harwood LLP has advised British chocolatier Hotel Chocolat on its £22 million placing through the issue of 9.78 million new ordinary shares at 225 ..

More

28 Aug 2019

From News

Stephenson Harwood advises on £139 million takeover of easyHotel

Law firm Stephenson Harwood LLP is advising easyHotel on its £139 million takeover by a consortium consisting of Ivanhoé Cambridge and ICAMAP Investments.

More

23 Jul 2019

From Insights

The new Prospectus Regulation

The European Union’s new Prospectus Regulation1 came into force on 20 July 2017, however the bulk of the changes it brings to the existing prospectus regime were imple..

More

03 Dec 2018

From News

Stephenson Harwood advises Manolete Partners Plc on £76 million IPO

Law firm Stephenson Harwood LLP has advised Manolete Partners Plc on its £76 million IPO and admission to AIM.

More

30 Apr 2018

From News

Stephenson Harwood advises finnCap on £10 million IPO for KRM22

Law firm Stephenson Harwood LLP has advised Nominated Advisor and broker, finnCap Ltd, on the AIM IPO of KRM22 Plc, a closed-ended investment company, and its simultan..

More

19 Apr 2018

From News

Stephenson Harwood promotes eight to partnership

Law firm Stephenson Harwood LLP has promoted five lawyers to partner and three lawyers to local partner, effective 1 May 2018.

More

19 Oct 2017

From News

Stephenson Harwood advises Novacyt SA on AIM IPO

Law firm Stephenson Harwood LLP has advised Novacyt SA on its €25 million AIM IPO.

More

11 Sep 2017

From News

Stephenson Harwood advises on reorganisation of S E A Holdings Limited and Asian Growth Properties Limited

Law firm Stephenson Harwood has advised S E A Holdings Limited (SEA), Asian Growth Properties Limited (AGP) and Nan Luen International Limited (NLI), on their reorgani..

More

05 May 2017

From News

Stephenson Harwood advises Snap-on on US$72 million Norbar Torque Tools acquisition

Law firm Stephenson Harwood LLP has advised Snap-on Incorporated, a global manufacturer and marketer of tools and equipment, as well as diagnostics, repair information..

More

29 Sep 2016

From News

Stephenson Harwood advises easyHotel on £38 million share placing

Law firm Stephenson Harwood LLP has advised easyHotel plc on its secondary fundraising, securing £38 million to fund expansion across the UK and Europe.

More

26 Jul 2016

From News

Stephenson Harwood advises Inflection Management Corporation on recommended offer for Superglass Holdings Plc

Law firm Stephenson Harwood LLP has advised Inflection Management Corporation on its £13.2 million recommended public takeover and refinancing of Superglass Holdings P..

More

09 Jun 2016

From Insights

An inside job

MAR introduces new rules on delaying the release of inside information and requirements in the keeping of insider lists. Tom Page, discusses the obligation on issuers ..

More

05 May 2016

From News

Stephenson Harwood advises Hotel Chocolat on IPO

International law firm Stephenson Harwood LLP has advised Hotel Chocolat Group plc on its initial public offering (IPO) and successful £167 million flotation on AIM.

More

03 Feb 2016

From News

Stephenson Harwood leads on £182 million cross border acquisition

Law firm Stephenson Harwood LLP has advised longstanding client AIM Group Ltd (AIM Group) on its £182 million cross border sale to Liberty Hall Capital Partners (Liber..

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.